技术与方法 |
|
|
|
|
抗凝蛋白EH体外活性检测条件的建立 |
秦晓永1, 于爱平2, 王文文3, 毕建进2, 郭晓军1, 袁洪水1, 吴祖泽2, 靳继德2, 朱宝成1 |
1. 河北农业大学生命科学学院 保定 071001;
2. 军事医学科学院放射与辐射医学研究所 北京 100850;
3. 天津大学化工学院 天津 300072 |
|
The Antithrombin Activity Detection of EH in Vitro |
QIN Xiao-yong1, YU Ai-ping2, WANG Wen-wen3, BI Jian-jin2, GUO Xiao-jun1, YUAN Hong-shui1, WU Zu-ze2, JIN Ji-de2, ZHU Bao-cheng1 |
1. College of Life Science, Agricultural University of Hebei, Baoding 071001, China;
2. Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China;
3. School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China |
引用本文:
秦晓永, 于爱平, 王文文, 毕建进, 郭晓军, 袁洪水, 吴祖泽, 靳继德, 朱宝成. 抗凝蛋白EH体外活性检测条件的建立[J]. 中国生物工程杂志, 2011, 31(5): 108-112.
QIN Xiao-yong, YU Ai-ping, WANG Wen-wen, BI Jian-jin, GUO Xiao-jun, YUAN Hong-shui, WU Zu-ze, JIN Ji-de, ZHU Bao-cheng. The Antithrombin Activity Detection of EH in Vitro. China Biotechnology, 2011, 31(5): 108-112.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I5/108
|
[1] Loscalzo J. Thrombin inhibitors in fibrinolysis: a Hobson's choice of alternatives. Circulation, 1996, 94(5): 863-865.
[2] Wallace A, Dennis S, Hofsteenge J, et al. Contribution of the N-terminal region of hirudin to its interaction with thrombin. Biochemistry, 1,28(26): 10079-10084.
[3] Wirsching F, Opitz T, Dietrich R, et al. Display of functional thrombin inhibitor hirudin on the surface of phage M13. Gene, 1997,204(1-2): 177-184.
[4] Syed S, Schyler P D, Kulczycky M, et al. Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albumin. Blood, 1997,89(9): 3243-3252.
[5] Eisenberg P R, Siegel J E, Abendschein D R, et al. Importance of factor Xa in determining the procoagulant activity of whole-blood clots. J Clin Invest, 1993,91(5): 1877-1883.
[6] McKenzie C R, Abendschein D R, Eisenberg P R. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus- associated factor Xa. Arterioscler Thromb Vasc Biol, 1996,16(10): 1285-1291.
[7] Zhang C L, Yu A P, Yuan B, et al. Construction and functional evaluation of hirudin derivatives with low bleeding risk. Thromb Haemost, 2008,99: 324-330.
[8] 国家药典委员会. 《中华人民共和国药典》2005年版第二部. 北京: 化学工业出版社, 2005,866-867. Chinese Pharmacopoeia Comission. Chinese Pharmacopoeia. 2nd ed, Beijing: Chemical Industry Press, 2005, 866-867.
[9] 雷丹青, 刘绵林, 周先丽. 发色底物法测定注射用降纤酶中类凝血酶的含量. 中国现代应用药学杂志, 2005, 18 (6): 498-500. Lei D Q, Liu J L, Zhou X L. Chinese Journal of Modern Applied Pharmacy, 2005, 18 (6): 498-500.
[10] 丁有学, 张翊, 郭莹, 等. 重组水蛭素生物学活性检测参考品的研制备和标定.中国生物制品学杂志, 2005, 18 (6): 498-500. Ding Y X, Zhang Y, Guo Y, et al. Chin J Biologicals, 2005, 18 (6): 498-500.
[11] Saporito-Irwin S M, Van Nostrand W E. Coagulation Factor XIa Cleaves the RHDS Sequence and Abolishes the Cell Adhesive Properties of the Amyloid β-Protein. J. Biol. Chem, 1995, 270 (44): 26265-26269.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|